December 1, 2023

Lead Principal Investigator Rebekka Schneider-Kramann presents the clinical plan and positioning of tasquinimod in myelofibrosis, audiocast summary

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use functional cookies to store settings for this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Functional

Functional cookies help to perform certain functionalities like saving the selected language.

Cookie	Duration	Description
pll_language	12 months	Cookie used to store selected language on www.activebiotech.com. It does not store any personal data.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-functional	12 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". It does not store any personal data.
cookielawinfo-checkbox-necessary	12 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". It does not store any personal data.
CookieLawInfoConsent	12 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy	12 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.